Denali Therapeutics Inc. (DNLI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US24823R1059
Denali Therapeutics Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -555.34 m USD |
| EBIT | -512.44 m USD |
| Net income | -512.54 m USD |
| Diluted EPS – continuing operations | -2.97 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Denali Therapeutics Inc.
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
More stocks
- Mobimo Holding AG (MOBN.SW)
- Shandong Weigao Blood (603014.SS)
- CES Energy Solutions Corp (CEU.TO)
- Sugi Holdings Co Ltd (7649.T)
- Beijing Capital Co Ltd (600008.SS)
- Jilin Aodong Pharmaceutical Group Co Ltd (000623.SZ)
- CAL-MAINE FOODS INC (CALM)
- Guangzhou Baiyun International Airport Co Ltd (600004.SS)
- CBIZ, Inc. (CBZ)
- Huaxi Securities Co Ltd Class A (002926.SZ)
- Qinhuangdao Port Co Ltd (601326.SS)
- Shenzhen hongfuhan Technology Co. Ltd. (301086.SZ)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.